Provided by Tiger Trade Technology Pte. Ltd.

Novavax

8.45
-0.5000-5.59%
Post-market: 8.500.0500+0.59%19:59 EDT
Volume:3.94M
Turnover:33.77M
Market Cap:1.37B
PE:3.28
High:8.96
Open:8.84
Low:8.44
Close:8.95
52wk High:11.97
52wk Low:5.01
Shares:162.50M
Float Shares:136.72M
Volume Ratio:0.99
T/O Rate:2.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.58
EPS(LYR):2.58
ROE:-898.20%
ROA:25.72%
PB:-10.75
PE(LYR):3.28

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Goldman Sachs, Domino's Pizza, Pattern Group

Reuters
·
Oct 14, 2025

BUZZ-Novavax falls as top investor urges sale over poor COVID shot rollout

Reuters
·
Oct 14, 2025

BRIEF-Shah Capital Recommends Immediate Formal Strategic Review For Sale Of Novavax

Reuters
·
Oct 14, 2025

Shah Capital: Recommends Immediate Formal Strategic Review for Sale of Novavax

THOMSON REUTERS
·
Oct 14, 2025

Shah Capital: Currently Owns 7.2% of Novavax

THOMSON REUTERS
·
Oct 14, 2025

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 14, 2025

Novavax Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Oct 11, 2025

Novavax Inc. Stock Slides 3.5%, Underperforms Peers

Dow Jones
·
Oct 10, 2025

Trump Excludes Generics From Big Pharma Tariff Plan

Dow Jones
·
Oct 09, 2025

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 08, 2025

Novavax Inc - Transfer Completion Triggers $25 Mln Payment From Sanofi to Novavax - SEC Filing

THOMSON REUTERS
·
Oct 07, 2025

Novavax Inc - Completed Transfer of Marketing Authorization for Its Covid-19 Vaccine, Nuvaxovid(Reg) to Sanofi, in European Union

THOMSON REUTERS
·
Oct 07, 2025

Novavax Inc - Anticipates Receipt of Payment in the First Quarter of 2026

THOMSON REUTERS
·
Oct 07, 2025

Novavax Completes EU Marketing Authorization Transfer for Nuvaxovid to Sanofi, Receives $25 Million Milestone Payment

Reuters
·
Oct 07, 2025

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

THOMSON REUTERS
·
Oct 07, 2025

Novavax Inc - Eligible for Future Milestones and Royalties

THOMSON REUTERS
·
Oct 07, 2025

Novavax- for Combination Products Developed by Sanofi Including Co's Covid-19 Vaccine, Eligible to GET up to Additional $350 Mln in Future Milestones

THOMSON REUTERS
·
Oct 07, 2025